Year: 2018
Language: English
Author(s): Jovan Antovic
In the Tuesday afternoon session entitled Chromogenic Factor IX Assay in Laboratory Diagnosis and Monitoring of Treatment in Hemophilia B – To be Aware of Challenges, Jovan Antovic presents data comparing one-stage assays with chromogenic assays for quantifying clotting factor activity, focusing on the challenges presented by their use in diagnosis.
The Report on Annual Global Survey (AGS) includes demographic and treatment data, providing a global snapshot of people with hemophilia,
The World Federation of Hemophilia invited representatives from its national member organizations, national governments, healthcare providers, industry partners, and other
A summary of discussions held at the Thirteenth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
A summary of discussions held at the Twelfth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
Welcome to this exciting webinar, a collaborative effort between the Nurses Committees of the European Association for Haemophilia and Allied
This video gives a quick introduction to ultra-long half-life (UHL) clotting factor replacement therapy. Learn more about different treatment options
